Left Atrial Appendage Closure Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Sep 2021
  • Pages: 120
  • SKU: IRTNTR44439
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The left atrial appendage closure market has the potential to grow by USD 1.67 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 17.64%.

This left atrial appendage closure market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (epicardial LAA closure device and endocardial LAA closure device) and geography (North America, Europe, Asia, and ROW). The left atrial appendage closure market report also offers information on several market vendors, including Abbott Laboratories, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Johnson and Johnson Inc., Lepu Medical Technology (Beijing) Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB, and SentreHEART Inc. among others.

What will the Left Atrial Appendage Closure Market Size be in 2021?

Browse TOC and LoE with selected illustrations and example pages of Left Atrial Appendage Closure Market

 Get Your FREE Sample Now!

Left Atrial Appendage Closure Market: Key Drivers and Trends

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The increasing incidences of atrial fibrillation is notably driving the left atrial appendage closure market growth, although factors such as shortage of skilled surgeons to perform LAA closure procedures may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the left atrial appendage closure industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

This left atrial appendage closure market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Left Atrial Appendage Closure Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Johnson and Johnson Inc.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB
  • SentreHEART Inc.

 

This statistical study of the left atrial appendage closure market encompasses successful business strategies deployed by the key vendors. The left atrial appendage closure market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The left atrial appendage closure market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Left Atrial Appendage Closure Market?

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the left atrial appendage closure market in North America. Market growth in this region will be slower than the growth of the market in other regions.

Atrial fibrillation is extremely common in the US, and according to the CDC, it is estimated that about 2.7-6 million people in the US experience symptoms of atrial fibrillation, and the number is expected to increase with the growing number of geriatric people in the country. This will facilitate the left atrial appendage closure market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Left Atrial Appendage Closure Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The left atrial appendage closure market share growth by the epicardial LAA closure device segment will be significant during the forecast period. The epicardial LAA devices market is expected to grow at a lesser rate than endocardial devices owing to limited clinical evidence and less number of product approvals. However, the researchers are looking to conduct more clinical trials to evaluate the benefits of the epicardial approach. The advantages of epicardial devices over endocardial devices will present growth opportunities in the market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the left atrial appendage closure market size and actionable market insights on post COVID-19 impact on each segment.

 

Left Atrial Appendage Closure Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 17.64%

Market growth 2021-2025

$ 1.67 billion

Market structure

Concentrated

YoY growth (%)

14.74

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Canada, Germany, UK, China, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Johnson and Johnson Inc., Lepu Medical Technology (Beijing) Co. Ltd., Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB, and SentreHEART Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Left Atrial Appendage Closure Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive left atrial appendage closure market growth during the next five years
  • Precise estimation of the left atrial appendage closure market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the left atrial appendage closure industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of left atrial appendage closure market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Epicardial LAA closure device - Market size and forecast 2020-2025
    • Endocardial LAA closure device - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

    • Customer landscape

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Overview
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Append Medical
    • AtriCure Inc.
    • Boston Scientific Corp.
    • Cardia Inc.
    • Johnson and Johnson Inc.
    • Lepu Medical Technology (Beijing) Co. Ltd.
    • Lifetech Scientific (Shenzhen) Co. Ltd.
    • Occlutech International AB
    • SentreHEART Inc.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your FREE sample now!
    The left atrial appendage closure market growth will increase by $1640.90 million during 2019-2024.
    The left atrial appendage closure market is expected to grow at a CAGR of 30.47% during 2019-2024.
    Technavio has segmented the left atrial appendage closure market by product (Epicardial LAA closure device and Endocardial LAA closure device) and geographic (Europe, North America, APAC, and ROW).
    Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., Occlutech International AB are a few of the key vendors in the left atrial appendage closure market.
    Europe will register the highest growth rate of 40.38% among the other regions. Therefore, the left atrial appendage closure market in Europe is expected to garner significant business opportunities for the vendors during the forecast period.
    The key factors driving the left atrial appendage closure market growth are:
    • Increasing incidences of atrial fibrillation
    The left atrial appendage closure market vendors should focus on grabbing business opportunities from the epicardial laa closure device segment as it accounted for the largest market share in the base year.
    Safe and Secure SSL Encrypted
    Technavio

    Single User:

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Want to customize this report?

    This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

    We offer $1000 worth of FREE customization at the time of purchase
    Technavio
    Enquire Before Buying
    1. Home
    2. Health Care
    3. Published Report
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>